首页> Clinical pharmacology in drug development> The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects.

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects.

导出 LinkOut

翻译打印收藏纠错

第一作者： Martin O,Behm

第一单位： Merck & Co., Inc., Whitehouse Station, NJ, USA.

作者： Martin O,Behm ^[1] ; Teddy,Kosoglou ^[1] ; André M M,Miltenburg ^[1] ; Jing,Li ^[1] ; Paul,Statkevich ^[1] ; Amy O,Johnson-Levonas ^[1] ; Monika,Martinho ^[1] ; Paul,Fackler ^[1]

作者单位： Merck & Co., Inc., Whitehouse Station, NJ, USA. ^[1]

关键词 PAR-1 food interaction pharmacokinetics vorapaxar

DOI 10.1002/cpdd.38

PMID 27121935

发布时间 2016-04-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览30

Clinical pharmacology in drug development

2013年2卷4期

310-5页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览30

点击下载本期目录封面

Clinical pharmacology in drug development

2013年2卷4期

310-5页

检索历史清除

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects.

Clinical pharmacology in drug development

相似文献

同项目论文

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects.

Clinical pharmacology in drug development

相似文献

同项目论文

Clinical pharmacology in drug development

相关期刊

检索历史清除